Literature DB >> 16828170

Clinical utility of 2',5'-oligoadenylate synthetase activity measurement: using whole blood as a highly sensitive method to detect the effects of IFN.

Kazuko Uno1, Yoshiki Suginoshita, Kazuhiro Kakimi, Yasunori Moriyasu, Koji Nakano, Naoto Nakamura, Toshio Fujita, Yoshihiro Horino, Takayuki Sato, Tsunataro Kishida.   

Abstract

Research progress on the pleiotropic effects of interferons (IFN) has thus far required detecting responses by weak IFN signals. The activity of 2',5'-oligoadenylate synthetase (2-5OAS) is a valuable indicator in the prognosis and IFN treatment of patients with viral diseases such as hepatitis B and C. Although serum samples generally are used to measure enzyme activity, their values depend on the exact conditions under which blood is stored and the degree of haemolysis that occurs during blood drawing or serum separation. This study presents an improved method of evaluating 2-5OAS activity by using whole blood samples containing heparin, which are frozen and then thawed, instead of serum samples. This method is more reliable, convenient, and 50-100 times more sensitive than the conventional methods of measuring serum 2-5OAS activity. The reliability and sensitivity of this improved method enables detection of the effects of low doses of oral IFN administration or changes in the IFN and cytokine system by infection or autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828170     DOI: 10.1016/j.jviromet.2006.05.005

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  Biodegradable nanogels for oral delivery of interferon for norovirus infection.

Authors:  Yunjeong Kim; Mahendra Thapa; Duy H Hua; Kyeong-Ok Chang
Journal:  Antiviral Res       Date:  2010-12-07       Impact factor: 5.970

Review 2.  Oromucosal Administration of Interferon to Humans.

Authors:  Manfred W Beilharz; Martin J Cummins; Alayne L Bennett; Joseph M Cummins
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.